Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Share-based Compensation (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Share-based Compensation for 10 consecutive years, with $627393.0 as the latest value for Q3 2025.

  • On a quarterly basis, Share-based Compensation rose 2.89% to $627393.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $2.4 million, a 5.5% increase, with the full-year FY2024 number at $2.6 million, down 5.23% from a year prior.
  • Share-based Compensation was $627393.0 for Q3 2025 at KORU Medical Systems, up from $415744.0 in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $881222.0 in Q1 2023 to a low of $389257.0 in Q4 2023.
  • A 5-year average of $680026.2 and a median of $699718.0 in 2024 define the central range for Share-based Compensation.
  • Peak YoY movement for Share-based Compensation: soared 103.39% in 2021, then plummeted 45.81% in 2023.
  • KORU Medical Systems' Share-based Compensation stood at $739922.0 in 2021, then fell by 2.92% to $718342.0 in 2022, then crashed by 45.81% to $389257.0 in 2023, then soared by 79.78% to $699789.0 in 2024, then dropped by 10.35% to $627393.0 in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Share-based Compensation are $627393.0 (Q3 2025), $415744.0 (Q2 2025), and $697590.0 (Q1 2025).